This article summarized the latest R&D progress of Tioconazole, the Mechanism of Action for Tioconazole, and the drug target R&D trends for Tioconazole.
EyePoint Pharmaceuticals, Inc., a company focused on improving life quality for severe eye condition patients, has revealed promising safety data for its key product candidate EYP-1901.